Back to search

Article

Aldo-keto reductase 1B: Much learned, much more to do

2023-12-16

Abstract excerpt

The Aldo-Keto Reductase 1B (AKR1B) subfamily was initially known for its association with the pathogenesis of secondary diabetic complications such as retinopathy, neuropathy, nephropathy, and cataracts. Unfortunately, over the past few decades, all drug development efforts targeting this family have failed for one reason or another. Recently, a growing body of evidence showing the deep involvement of AKR1B in met...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f4aeaddd-4772-5e14-b47f-e9e1ba3cb384
DOI
10.1016/j.hlife.2023.12.002
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aldo-keto reductase 1B: Much learned, much more to doDOI 10.1016/j.hlife.2023.12.002
Select a neighboring publication to make it the new centre.